Professional Seasonal Analysis for Trading

NewAmsterdam Pharma Company N.V. - Warrant (NAMSW)

Seasonality Analysis

Stocks 6 Years Analyzed

NewAmsterdam Pharma Company N.V. - Warrant Annual Seasonality Statistics

248.85%
Avg Annual Return
51.1%
Avg Monthly Win Rate
10/12
Positive Months
6
Years Analyzed

NewAmsterdam Pharma Company N.V. - Warrant Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 55.96%
40%
Weak
February 3.62%
50%
Weak
March WORST -26.54%
0%
Very Weak
April 22.07%
83%
Very Strong
May -24.09%
0%
Very Weak
June 0.36%
60%
Moderate
July BEST 164.08%
60%
Moderate
August 1.38%
40%
Weak
September 3.40%
40%
Weak
October 23.84%
100%
Very Strong
November 13.27%
80%
Very Strong
December 11.48%
60%
Moderate

NewAmsterdam Pharma Company N.V. - Warrant 2026 vs Historical Pattern

Current Position
77.39
Historical Avg Position
33.48
Deviation
+43.91
Performance
Significantly Above Average

NewAmsterdam Pharma Company N.V. - Warrant Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for NAMSW with overlay patterns, custom date ranges, and more.

Create Free Account

NewAmsterdam Pharma Company N.V. - Warrant Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

NewAmsterdam Pharma Company N.V. - Warrant Seasonal Historical Performance

Historical Performance

See historical average returns for NAMSW across multiple timeframes.

Create Free Account

About NewAmsterdam Pharma Company N.V. - Warrant (NAMSW) Seasonality

NewAmsterdam Pharma Company N.V. - Warrant (NAMSW) has been analyzed using 6 years of historical data to identify seasonal patterns. Classified under Stocks, NewAmsterdam Pharma Company N.V. - Warrant shows distinct seasonal tendencies based on historical data.

The strongest month for NewAmsterdam Pharma Company N.V. - Warrant is historically July, with an average return of 164.08% and a win rate of 60%. Conversely, March tends to be the weakest month, averaging -26.54% return.

Looking at the full calendar year, NewAmsterdam Pharma Company N.V. - Warrant has an average annual return of 248.85% with an overall monthly win rate of 51.1%. Out of 12 months, 10 typically show positive average returns.

The seasonal pattern for NewAmsterdam Pharma Company N.V. - Warrant has a consistency score of 48.1 (Poor), based on 6 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

NewAmsterdam Pharma Company N.V. - Warrant Seasonality FAQ

What is the best month to buy NewAmsterdam Pharma Company N.V. - Warrant (NAMSW)?

Historically, July has been the best month for NewAmsterdam Pharma Company N.V. - Warrant, with an average return of 164.08% and a win rate of 60%. However, past performance does not guarantee future results.

What is the worst month for NewAmsterdam Pharma Company N.V. - Warrant (NAMSW)?

Based on historical data, March has been the weakest month for NewAmsterdam Pharma Company N.V. - Warrant, with an average return of -26.54%. This is a historical observation and does not guarantee future results.

How reliable is NAMSW seasonality data?

The seasonality analysis for NewAmsterdam Pharma Company N.V. - Warrant is based on 6 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use NewAmsterdam Pharma Company N.V. - Warrant seasonality in my trading?

Use NewAmsterdam Pharma Company N.V. - Warrant (NAMSW) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.